Navigating the New Regulatory Frontier: Why VM-22 and ICS Demand a Strategic Response

Authored by James Beck, Senior Strategy Advisor, US, RNA Analytics

The US insurance landscape is undergoing a profound transformation. New regulations like Valuation Manual (VM)-22 for annuities, coupled with the global push for standardization embodied by the Insurance Capital Standard (ICS), are demanding an unprecedented level of sophistication from insurers. These aren't just compliance hurdles; they are a catalyst forcing the industry to modernize its technology, processes, and strategic thinking.

The Insurer's Struggle: Complexity and Computation

The core challenge for insurers lies in the move from formulaic, historical-based reserving to Principle-Based Reserving (PBR), which is inherently more complex and computationally intensive.

VM-22: A New Calculus for Annuity Reserving

VM-22, adopted with an initial effective date of Jan 1, 2026 and a three-year transition period, compliance becomes mandatory for all new business by January 1, 2029, fundamentally changes how reserves for non-variable annuities are calculated.

  • Scenario-Based Projections: VM-22 requires extensive stochastic simulations often thousands of economic scenarios to capture tail risk for the Stochastic Reserve (SR). For companies without prior experience in PBR (like VM-20 or VM-21), this is a massive operational lift.

  • Data and Systems Strain: The new methodology necessitates integrated asset-liability modeling and the use of company-specific assumptions with prudent margins. This means greater data volume, more complex model inputs, and the need for modeling software that can handle these massive, dynamic projections and provide clear audit trails.

  • Volatile Results: Initial field testing has shown significant variability in reserve impacts based on product design and assumption choices, leading to potential fluctuations in capital ratios and making capital management and pricing more challenging.

ICS: A Global Mandate for Consistency

For internationally active insurance groups (IAIGs), the global ICS, part of the broader Common Framework (ComFrame) by the International Association of Insurance Supervisors (IAIS) adds another layer of complexity.

  • Group-Wide Consolidation: The ICS aims to establish a single, group-wide capital standard, forcing IAIGs to reconcile disparate local regulatory frameworks with a new, consistent global measure.

  • Valuation and Capital Reconciliation: The ICS introduces specific requirements for the valuation of assets and liabilities, capital resource classification, and the calculation of a risk-based capital requirement, which must be calibrated to a target of 99.5% Value-at-Risk (VaR) over a one-year horizon.

  • US Comparability: While the US continues to advocate for the Aggregation Method (AM) to be deemed comparable to the ICS, IAIGs must still invest significant resources in understanding, calculating, and potentially reporting on both frameworks to maintain regulatory flexibility.

In essence, insurers are being asked to do more complex calculations, with more data, across more scenarios, with greater frequency, all while ensuring auditability and strategic alignment. The traditional, siloed approach to actuarial and risk modeling is simply no longer viable.

RNA Analytics: Alleviating the Regulatory Headaches

At RNA Analytics, we recognize that compliance doesn't have to be a drag on innovation. Our solutions are specifically designed to transform these regulatory demands from a burden into an opportunity for strategic enhancement.

Our R3S software suite and expert consulting services address the core challenges of VM-22 and ICS head-on:

1. Optimized for PBR and Stochastic Modeling

Our R3S Modeler is built for the dynamic and principles-based nature of modern regulation.

  • High-Performance Stochastic Engine: It provides the necessary computational power to run the thousands of required economic scenarios (including those from the NAIC’s Generator of Economic Scenarios, or GOES) quickly and efficiently, accommodating the iterative model development and scenario reduction techniques necessary for VM-22 compliance.

  • Integrated ALM: The system supports the deep integration of asset and liability modeling, which is crucial for accurately reflecting the market-aligned reserve methodology of VM-22.

2. Enhanced Governance and Auditability

Complexity increases risk. Our solutions provide features to materially improve transparency and control of model inputs and outputs, over the modeling process.

  • R3S Workflow Manager: This dedicated production environment provides a user-friendly interface for running and managing models, offering essential security, audit, and governance features. It ensures that complex, multi-step VM-22 calculations and ICS aggregations are consistent, controlled, and fully auditable, simplifying the often-onerous VM-31 reporting requirements.

  • Consistent Platform: By using a single software suite for all financial, risk, and actuarial analysis from product pricing and statutory valuation (VM-22) to economic capital (ICS) insurers ensure a consistent set of calculations and assumptions across the organization, eliminating discrepancies and reducing reporting risk.

3. Flexibility for an Evolving Regulatory Landscape

The ICS and VM-22 are living standards. Insurers need a platform that can adapt without requiring a total overhaul every time guidance evolves.

  • Modular Design: R3S Modeler’s modular design and extensive Standard Code library allow actuaries to quickly adapt models to incorporate new regulatory elements such as changes in prescribed assumptions, single-scenario testing, or new risk charges without extensive re-coding.

  • Strategic Opportunity: Beyond compliance, our tools enable insurers to leverage the new granular data and risk insights required by VM-22 and ICS for better strategic decision-making. This includes improved product pricing, more effective capital allocation, and a deeper understanding of risk drivers.

Turning Compliance into Competitive Advantage

VM-22 and ICS are not temporary mandates; they represent the future of insurance financial reporting and risk management. The firms that treat them as a minimal compliance exercise will fall behind. Those that see them as an opportunity to build a modern, high-performance, and integrated modeling environment will gain a powerful competitive edge.

RNA Analytics offers the expertise and the cutting-edge technology to navigate this transition. By adopting a unified, high-performance platform, US insurers can not only achieve compliance but also unlock the strategic value hidden within their complex regulatory obligations.

Would you like to schedule a consultation with an RNA Analytics expert to assess your current VM-22 and ICS readiness?

Email info@rnaanalytics.com

RNA Analytics